{"id":16346,"date":"2020-06-29T10:11:38","date_gmt":"2020-06-29T14:11:38","guid":{"rendered":"https:\/\/medicarereport.org\/?p=16346"},"modified":"2020-06-29T10:12:21","modified_gmt":"2020-06-29T14:12:21","slug":"coalition-of-drugmakers-to-unveil-1b-venture-to-pursue-antibiotics","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=16346","title":{"rendered":"Coalition of drugmakers to unveil $1B venture to pursue antibiotics"},"content":{"rendered":"<p>(By\u00a0Katie Adams\u00a0 for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>Several of the pharmaceutical industry&#8217;s top drugmakers are forming a $1 billion antibiotic innovation venture to address patients&#8217; increasing resistance to existing treatments, according to STAT.\u00a0 Continue reading article <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/coalition-of-drugmakers-to-unveil-1b-venture-to-pursue-antibiotics.html\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-7795\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs-300x201.jpg\" alt=\"\" width=\"300\" height=\"201\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs-300x201.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Katie Adams\u00a0 for Becker&#8217;s Hospital Review) Several of the pharmaceutical industry&#8217;s top drugmakers are forming a $1 billion antibiotic innovation<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15,1],"tags":[],"class_list":["post-16346","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16346"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16346\/revisions"}],"predecessor-version":[{"id":16348,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16346\/revisions\/16348"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}